Compile Data Set for Download or QSAR
Report error Found 116 Enz. Inhib. hit(s) with all data for entry = 13495
TargetDual specificity protein kinase CLK3(Homo sapiens)
Redona Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 799432BDBM799432(US12583825, Example 101)
Affinity DataIC50: 1.20nMAssay Description:This example demonstrates the ability of the compounds of the disclosure to degrade a Nano luciferase-BRO9 fusion protein in a cell-based degradation...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK3(Homo sapiens)
Redona Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 799384BDBM799384(US12583825, Example 53)
Affinity DataIC50: 1.5nMAssay Description:This example demonstrates the ability of the compounds of the disclosure to degrade a Nano luciferase-BRO9 fusion protein in a cell-based degradation...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK3(Homo sapiens)
Redona Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 799383BDBM799383(US12583825, Example 52)
Affinity DataIC50: 1.5nMAssay Description:This example demonstrates the ability of the compounds of the disclosure to degrade a Nano luciferase-BRO9 fusion protein in a cell-based degradation...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK3(Homo sapiens)
Redona Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 799381BDBM799381(US12583825, Example 50)
Affinity DataIC50: 1.5nMAssay Description:This example demonstrates the ability of the compounds of the disclosure to degrade a Nano luciferase-BRO9 fusion protein in a cell-based degradation...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK3(Homo sapiens)
Redona Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 799387BDBM799387(US12583825, Example 56)
Affinity DataIC50: 1.5nMAssay Description:This example demonstrates the ability of the compounds of the disclosure to degrade a Nano luciferase-BRO9 fusion protein in a cell-based degradation...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK3(Homo sapiens)
Redona Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 799428BDBM799428(US12583825, Example 97)
Affinity DataIC50: 1.70nMAssay Description:This example demonstrates the ability of the compounds of the disclosure to degrade a Nano luciferase-BRO9 fusion protein in a cell-based degradation...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK3(Homo sapiens)
Redona Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 799385BDBM799385(US12583825, Example 54)
Affinity DataIC50: 1.90nMAssay Description:This example demonstrates the ability of the compounds of the disclosure to degrade a Nano luciferase-BRO9 fusion protein in a cell-based degradation...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK3(Homo sapiens)
Redona Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 799276BDBM799276(US12583825, Example 4)
Affinity DataIC50: 2.10nMAssay Description:This example demonstrates the ability of the compounds of the disclosure to degrade a Nano luciferase-BRO9 fusion protein in a cell-based degradation...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK3(Homo sapiens)
Redona Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 799388BDBM799388(US12583825, Example 57)
Affinity DataIC50: 2.76nMAssay Description:This example demonstrates the ability of the compounds of the disclosure to degrade a Nano luciferase-BRO9 fusion protein in a cell-based degradation...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK3(Homo sapiens)
Redona Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 799433BDBM799433(US12583825, Example 102)
Affinity DataIC50: 2.90nMAssay Description:This example demonstrates the ability of the compounds of the disclosure to degrade a Nano luciferase-BRO9 fusion protein in a cell-based degradation...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK3(Homo sapiens)
Redona Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 799406BDBM799406(US12583825, Example 75)
Affinity DataIC50: 3.40nMAssay Description:This example demonstrates the ability of the compounds of the disclosure to degrade a Nano luciferase-BRO9 fusion protein in a cell-based degradation...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK3(Homo sapiens)
Redona Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 799431BDBM799431(US12583825, Example 100)
Affinity DataIC50: 3.70nMAssay Description:This example demonstrates the ability of the compounds of the disclosure to degrade a Nano luciferase-BRO9 fusion protein in a cell-based degradation...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK3(Homo sapiens)
Redona Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 799369BDBM799369(US12583825, Example 38)
Affinity DataIC50: 4.16nMAssay Description:This example demonstrates the ability of the compounds of the disclosure to degrade a Nano luciferase-BRO9 fusion protein in a cell-based degradation...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK3(Homo sapiens)
Redona Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 799344BDBM799344(US12583825, Example 13)
Affinity DataIC50: 4.30nMAssay Description:This example demonstrates the ability of the compounds of the disclosure to degrade a Nano luciferase-BRO9 fusion protein in a cell-based degradation...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK3(Homo sapiens)
Redona Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 799405BDBM799405(US12583825, Example 74)
Affinity DataIC50: 4.80nMAssay Description:This example demonstrates the ability of the compounds of the disclosure to degrade a Nano luciferase-BRO9 fusion protein in a cell-based degradation...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK3(Homo sapiens)
Redona Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 799414BDBM799414(US12583825, Example 83)
Affinity DataIC50: 4.90nMAssay Description:This example demonstrates the ability of the compounds of the disclosure to degrade a Nano luciferase-BRO9 fusion protein in a cell-based degradation...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK3(Homo sapiens)
Redona Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 799379BDBM799379(US12583825, Example 48)
Affinity DataIC50: 4.90nMAssay Description:This example demonstrates the ability of the compounds of the disclosure to degrade a Nano luciferase-BRO9 fusion protein in a cell-based degradation...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK3(Homo sapiens)
Redona Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 799422BDBM799422(US12583825, Example 91)
Affinity DataIC50: 5.10nMAssay Description:This example demonstrates the ability of the compounds of the disclosure to degrade a Nano luciferase-BRO9 fusion protein in a cell-based degradation...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK3(Homo sapiens)
Redona Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 799430BDBM799430(US12583825, Example 99)
Affinity DataIC50: 5.80nMAssay Description:This example demonstrates the ability of the compounds of the disclosure to degrade a Nano luciferase-BRO9 fusion protein in a cell-based degradation...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK3(Homo sapiens)
Redona Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 799424BDBM799424(US12583825, Example 93)
Affinity DataIC50: 6.20nMAssay Description:This example demonstrates the ability of the compounds of the disclosure to degrade a Nano luciferase-BRO9 fusion protein in a cell-based degradation...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK3(Homo sapiens)
Redona Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 799382BDBM799382(US12583825, Example 51)
Affinity DataIC50: 7.26nMAssay Description:This example demonstrates the ability of the compounds of the disclosure to degrade a Nano luciferase-BRO9 fusion protein in a cell-based degradation...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK3(Homo sapiens)
Redona Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 799419BDBM799419(US12583825, Example 88)
Affinity DataIC50: 8.80nMAssay Description:This example demonstrates the ability of the compounds of the disclosure to degrade a Nano luciferase-BRO9 fusion protein in a cell-based degradation...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK3(Homo sapiens)
Redona Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 799443BDBM799443(US12583825, Example 112)
Affinity DataIC50: 8.80nMAssay Description:This example demonstrates the ability of the compounds of the disclosure to degrade a Nano luciferase-BRO9 fusion protein in a cell-based degradation...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK3(Homo sapiens)
Redona Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 799401BDBM799401(US12583825, Example 70)
Affinity DataIC50: 9.10nMAssay Description:This example demonstrates the ability of the compounds of the disclosure to degrade a Nano luciferase-BRO9 fusion protein in a cell-based degradation...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK3(Homo sapiens)
Redona Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 799271BDBM799271(US12583825, Example 1)
Affinity DataIC50: 9.10nMAssay Description:This example demonstrates the ability of the compounds of the disclosure to degrade a Nano luciferase-BRO9 fusion protein in a cell-based degradation...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK3(Homo sapiens)
Redona Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 799421BDBM799421(US12583825, Example 90)
Affinity DataIC50: 9.37nMAssay Description:This example demonstrates the ability of the compounds of the disclosure to degrade a Nano luciferase-BRO9 fusion protein in a cell-based degradation...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK3(Homo sapiens)
Redona Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 799413BDBM799413(US12583825, Example 82)
Affinity DataIC50: 9.70nMAssay Description:This example demonstrates the ability of the compounds of the disclosure to degrade a Nano luciferase-BRO9 fusion protein in a cell-based degradation...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK3(Homo sapiens)
Redona Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 799435BDBM799435(US12583825, Example 104)
Affinity DataIC50: 10.4nMAssay Description:This example demonstrates the ability of the compounds of the disclosure to degrade a Nano luciferase-BRO9 fusion protein in a cell-based degradation...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK3(Homo sapiens)
Redona Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 799415BDBM799415(US12583825, Example 84)
Affinity DataIC50: 10.6nMAssay Description:This example demonstrates the ability of the compounds of the disclosure to degrade a Nano luciferase-BRO9 fusion protein in a cell-based degradation...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK3(Homo sapiens)
Redona Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 799365BDBM799365(US12583825, Example 34)
Affinity DataIC50: 10.9nMAssay Description:This example demonstrates the ability of the compounds of the disclosure to degrade a Nano luciferase-BRO9 fusion protein in a cell-based degradation...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK3(Homo sapiens)
Redona Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 799377BDBM799377(US12583825, Example 46)
Affinity DataIC50: 12.7nMAssay Description:This example demonstrates the ability of the compounds of the disclosure to degrade a Nano luciferase-BRO9 fusion protein in a cell-based degradation...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK3(Homo sapiens)
Redona Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 799397BDBM799397(US12583825, Example 66)
Affinity DataIC50: 13nMAssay Description:This example demonstrates the ability of the compounds of the disclosure to degrade a Nano luciferase-BRO9 fusion protein in a cell-based degradation...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK3(Homo sapiens)
Redona Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 799380BDBM799380(US12583825, Example 49)
Affinity DataIC50: 14.4nMAssay Description:This example demonstrates the ability of the compounds of the disclosure to degrade a Nano luciferase-BRO9 fusion protein in a cell-based degradation...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK3(Homo sapiens)
Redona Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 799436BDBM799436(US12583825, Example 105)
Affinity DataIC50: 14.9nMAssay Description:This example demonstrates the ability of the compounds of the disclosure to degrade a Nano luciferase-BRO9 fusion protein in a cell-based degradation...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK3(Homo sapiens)
Redona Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 799360BDBM799360(US12583825, Example 29)
Affinity DataIC50: 15.4nMAssay Description:This example demonstrates the ability of the compounds of the disclosure to degrade a Nano luciferase-BRO9 fusion protein in a cell-based degradation...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK3(Homo sapiens)
Redona Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 799386BDBM799386(US12583825, Example 55)
Affinity DataIC50: 15.6nMAssay Description:This example demonstrates the ability of the compounds of the disclosure to degrade a Nano luciferase-BRO9 fusion protein in a cell-based degradation...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK3(Homo sapiens)
Redona Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 799375BDBM799375(US12583825, Example 44)
Affinity DataIC50: 15.8nMAssay Description:This example demonstrates the ability of the compounds of the disclosure to degrade a Nano luciferase-BRO9 fusion protein in a cell-based degradation...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK3(Homo sapiens)
Redona Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 799412BDBM799412(US12583825, Example 81)
Affinity DataIC50: 15.8nMAssay Description:This example demonstrates the ability of the compounds of the disclosure to degrade a Nano luciferase-BRO9 fusion protein in a cell-based degradation...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK3(Homo sapiens)
Redona Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 799358BDBM799358(US12583825, Example 27)
Affinity DataIC50: 16.1nMAssay Description:This example demonstrates the ability of the compounds of the disclosure to degrade a Nano luciferase-BRO9 fusion protein in a cell-based degradation...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK3(Homo sapiens)
Redona Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 799273BDBM799273(US12583825, Example 2)
Affinity DataIC50: 16.6nMAssay Description:This example demonstrates the ability of the compounds of the disclosure to degrade a Nano luciferase-BRO9 fusion protein in a cell-based degradation...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK3(Homo sapiens)
Redona Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 799440BDBM799440(US12583825, Example 109)
Affinity DataIC50: 17.7nMAssay Description:This example demonstrates the ability of the compounds of the disclosure to degrade a Nano luciferase-BRO9 fusion protein in a cell-based degradation...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK3(Homo sapiens)
Redona Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 799425BDBM799425(US12583825, Example 94)
Affinity DataIC50: 18.6nMAssay Description:This example demonstrates the ability of the compounds of the disclosure to degrade a Nano luciferase-BRO9 fusion protein in a cell-based degradation...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK3(Homo sapiens)
Redona Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 799418BDBM799418(US12583825, Example 87)
Affinity DataIC50: 18.7nMAssay Description:This example demonstrates the ability of the compounds of the disclosure to degrade a Nano luciferase-BRO9 fusion protein in a cell-based degradation...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK3(Homo sapiens)
Redona Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 799446BDBM799446(US12583825, Example 115)
Affinity DataIC50: 19.4nMAssay Description:This example demonstrates the ability of the compounds of the disclosure to degrade a Nano luciferase-BRO9 fusion protein in a cell-based degradation...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK3(Homo sapiens)
Redona Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 799350BDBM799350(US12583825, Example 19)
Affinity DataIC50: 20.2nMAssay Description:This example demonstrates the ability of the compounds of the disclosure to degrade a Nano luciferase-BRO9 fusion protein in a cell-based degradation...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK3(Homo sapiens)
Redona Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 799400BDBM799400(US12583825, Example 69)
Affinity DataIC50: 20.6nMAssay Description:This example demonstrates the ability of the compounds of the disclosure to degrade a Nano luciferase-BRO9 fusion protein in a cell-based degradation...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK3(Homo sapiens)
Redona Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 799444BDBM799444(US12583825, Example 113)
Affinity DataIC50: 21.2nMAssay Description:This example demonstrates the ability of the compounds of the disclosure to degrade a Nano luciferase-BRO9 fusion protein in a cell-based degradation...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK3(Homo sapiens)
Redona Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 799371BDBM799371(US12583825, Example 40)
Affinity DataIC50: 21.7nMAssay Description:This example demonstrates the ability of the compounds of the disclosure to degrade a Nano luciferase-BRO9 fusion protein in a cell-based degradation...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK3(Homo sapiens)
Redona Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 799442BDBM799442(US12583825, Example 111)
Affinity DataIC50: 21.8nMAssay Description:This example demonstrates the ability of the compounds of the disclosure to degrade a Nano luciferase-BRO9 fusion protein in a cell-based degradation...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK3(Homo sapiens)
Redona Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 799364BDBM799364(US12583825, Example 33)
Affinity DataIC50: 23.3nMAssay Description:This example demonstrates the ability of the compounds of the disclosure to degrade a Nano luciferase-BRO9 fusion protein in a cell-based degradation...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

Displayed 1 to 50 (of 116 total ) | Next | Last >>
Jump to: